{"id":"limaprost","rwe":[{"pmid":"41597511","year":"2026","title":"The Effect of Comprehensive and Integrative Medical Services on Patients with Degenerative Lumbar Spinal Stenosis: A Randomized Controlled Study.","finding":"","journal":"Medicina (Kaunas, Lithuania)","studyType":"Clinical Study"},{"pmid":"41546687","year":"2026","title":"Use of pregabalin and limaprost in the conservative treatment of lumbar spinal stenosis: a systematic review of the current evidence.","finding":"","journal":"European journal of clinical pharmacology","studyType":"Clinical Study"},{"pmid":"41303739","year":"2025","title":"Efficacy of JOINS Tablet for Lumbar Spinal Stenosis: Prospective, Randomized, Open-Label Clinical Trial.","finding":"","journal":"Medicina (Kaunas, Lithuania)","studyType":"Clinical Study"},{"pmid":"40288523","year":"2025","title":"Letter to the Editor Regarding \"Comparative Study on the Efficacy of Pregabalin versus Limaprost in Patients with Lumbar Spinal Stenosis: A Prospective, Randomized Controlled Trial\".","finding":"","journal":"World neurosurgery","studyType":"Clinical Study"},{"pmid":"40253304","year":"2026","title":"The Patient-Reported Outcomes of Postoperative Prostaglandin E1 Derivative in Lumbar Spine Surgery: A Randomized, Double-Blind, Controlled Trial.","finding":"","journal":"Global spine journal","studyType":"Clinical Study"}],"tags":[{"label":"limaprost","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Prostaglandin E2 receptor EP1 subtype","category":"target"},{"label":"PTGER1","category":"gene"},{"label":"Active","category":"status"},{"label":"Thromboangiitis obliterans","category":"indication"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Vasodilator Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":98.027,"date":"","count":56,"signal":"Interstitial lung disease","source":"DrugCentral FAERS","actionTaken":"Reported 56 times (LLR=98)"},{"llr":62.581,"date":"","count":48,"signal":"Cardiac failure","source":"DrugCentral FAERS","actionTaken":"Reported 48 times (LLR=63)"},{"llr":46.276,"date":"","count":25,"signal":"Cerebral infarction","source":"DrugCentral FAERS","actionTaken":"Reported 25 times (LLR=46)"},{"llr":42.953,"date":"","count":28,"signal":"Hepatic function abnormal","source":"DrugCentral FAERS","actionTaken":"Reported 28 times (LLR=43)"},{"llr":40.567,"date":"","count":56,"signal":"Decreased appetite","source":"DrugCentral FAERS","actionTaken":"Reported 56 times (LLR=41)"},{"llr":37.875,"date":"","count":18,"signal":"Inappropriate antidiuretic hormone secretion","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=38)"},{"llr":35.354,"date":"","count":21,"signal":"Osteonecrosis of jaw","source":"DrugCentral FAERS","actionTaken":"Reported 21 times (LLR=35)"},{"llr":33.503,"date":"","count":38,"signal":"Platelet count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 38 times (LLR=34)"},{"llr":30.851,"date":"","count":10,"signal":"Haemorrhage subcutaneous","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=31)"},{"llr":27.595,"date":"","count":18,"signal":"Altered state of consciousness","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=28)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=LIMAPROST","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:52:35.538374+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:52:41.080550+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LIMAPROST","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:52:41.309143+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107456/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:52:41.997728+00:00"}},"allNames":"opalmon","offLabel":[],"synonyms":["opalmon","limaprost alfadex","ONO1206","ONO 1206","limaprost"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"PMDA"}],"brandName":"Opalmon","ecosystem":[{"indication":"Thromboangiitis obliterans","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"target":"Prostaglandin E2 receptor EP1 subtype","targets":[{"gene":"PTGER1","source":"DrugCentral","target":"Prostaglandin E2 receptor EP1 subtype","protein":"Prostaglandin E2 receptor EP1 subtype"}],"modality":"Small Molecule","drugClass":"limaprost","explanation":"","oneSentence":"","technicalDetail":"Limaprost acts as a selective agonist of the Prostaglandin E2 receptor EP1 subtype, which is involved in the regulation of vascular tone and inflammation. By activating this receptor, limaprost can help to reduce the production of pro-inflammatory mediators and improve blood flow to affected areas."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1581","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=LIMAPROST","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LIMAPROST","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:59:55.721980","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:52:43.592907+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"alprostadil","drugSlug":"alprostadil","fdaApproval":"1981-10-16","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"bupivacaine","drugSlug":"bupivacaine","fdaApproval":"1972-10-03","patentExpiry":"Mar 17, 2042","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"cloprostenol","drugSlug":"cloprostenol","fdaApproval":"","relationship":"same-target"},{"drugName":"dinoprost","drugSlug":"dinoprost","fdaApproval":"1976-05-18","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"dinoprostone","drugSlug":"dinoprostone","fdaApproval":"1977-08-23","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"epoprostenol","drugSlug":"epoprostenol","fdaApproval":"1995-09-20","patentExpiry":"Mar 15, 2027","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"iloprost","drugSlug":"iloprost","fdaApproval":"2004-12-29","patentExpiry":"Jul 18, 2044","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"latanoprost","drugSlug":"latanoprost","fdaApproval":"1996-06-05","patentExpiry":"Sep 12, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"levobupivacaine","drugSlug":"levobupivacaine","fdaApproval":"1999-08-05","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"mezlocillin","drugSlug":"mezlocillin","fdaApproval":"1981-09-21","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-target"}],"genericName":"limaprost","indications":{"approved":[{"name":"Thromboangiitis obliterans","source":"DrugCentral","snomedId":52403007,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"alprostadil","brandName":"alprostadil","genericName":"alprostadil","approvalYear":"1981","relationship":"same-target"},{"drugId":"bupivacaine","brandName":"bupivacaine","genericName":"bupivacaine","approvalYear":"1972","relationship":"same-target"},{"drugId":"cloprostenol","brandName":"cloprostenol","genericName":"cloprostenol","approvalYear":"","relationship":"same-target"},{"drugId":"dinoprost","brandName":"dinoprost","genericName":"dinoprost","approvalYear":"1976","relationship":"same-target"},{"drugId":"dinoprostone","brandName":"dinoprostone","genericName":"dinoprostone","approvalYear":"1977","relationship":"same-target"},{"drugId":"epoprostenol","brandName":"epoprostenol","genericName":"epoprostenol","approvalYear":"1995","relationship":"same-target"},{"drugId":"iloprost","brandName":"iloprost","genericName":"iloprost","approvalYear":"2004","relationship":"same-target"},{"drugId":"latanoprost","brandName":"latanoprost","genericName":"latanoprost","approvalYear":"1996","relationship":"same-target"},{"drugId":"levobupivacaine","brandName":"levobupivacaine","genericName":"levobupivacaine","approvalYear":"1999","relationship":"same-target"},{"drugId":"mezlocillin","brandName":"mezlocillin","genericName":"mezlocillin","approvalYear":"1981","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT07247071","phase":"","title":"Modifiable Risk Factors for Non-traumatic Subconjunctival Hemorrhage","status":"COMPLETED","sponsor":"Hallym University Kangnam Sacred Heart Hospital","startDate":"2022-12-22","conditions":["Subconjunctival Hemorrhage"],"enrollment":67,"completionDate":"2024-12-28"},{"nctId":"NCT04876612","phase":"NA","title":"Effect of Limaprost in Combination With Transforaminal Epidural Steroid Injection","status":"RECRUITING","sponsor":"Seoul National University","startDate":"2021-11-10","conditions":["Lumbar Spinal Stenosis"],"enrollment":104,"completionDate":"2025-08-31"},{"nctId":"NCT02125981","phase":"PHASE3","title":"The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-09-01","conditions":["Cervical Myelopathy"],"enrollment":160,"completionDate":"2023-04-01"},{"nctId":"NCT01888536","phase":"PHASE4","title":"A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis","status":"COMPLETED","sponsor":"Yungjin Pharm. Co., Ltd.","startDate":"2013-02","conditions":["Neurologic Claudication in Patients With Lumbar Spinal Stenosis"],"enrollment":182,"completionDate":"2014-02"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"L02U804092","INN_ID":"5899","UMLSCUI":"C0064987","chemblId":"CHEMBL2107456","ChEMBL_ID":"CHEMBL2107456","KEGG_DRUG":"D02722","DRUGBANK_ID":"DB09211","PUBCHEM_CID":"6438378","MESH_SUPPLEMENTAL_RECORD_UI":"C059238"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":67,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Jan 21","pmid":"41597511","title":"The Effect of Comprehensive and Integrative Medical Services on Patients with Degenerative Lumbar Spinal Stenosis: A Randomized Controlled Study.","journal":"Medicina (Kaunas, Lithuania)"},{"date":"2026 Jan 17","pmid":"41546687","title":"Use of pregabalin and limaprost in the conservative treatment of lumbar spinal stenosis: a systematic review of the current evidence.","journal":"European journal of clinical pharmacology"},{"date":"2025 Oct 23","pmid":"41303739","title":"Efficacy of JOINS Tablet for Lumbar Spinal Stenosis: Prospective, Randomized, Open-Label Clinical Trial.","journal":"Medicina (Kaunas, Lithuania)"},{"date":"2025 Jun","pmid":"40288523","title":"Letter to the Editor Regarding \"Comparative Study on the Efficacy of Pregabalin versus Limaprost in Patients with Lumbar Spinal Stenosis: A Prospective, Randomized Controlled Trial\".","journal":"World neurosurgery"},{"date":"2026 Jan","pmid":"40253304","title":"The Patient-Reported Outcomes of Postoperative Prostaglandin E1 Derivative in Lumbar Spine Surgery: A Randomized, Double-Blind, Controlled Trial.","journal":"Global spine journal"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:52:43.592907+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}